Encinitas, CA, United States of America

Mark S Juravic

This inventor holds 2 USPTO granted patents and 10 published patent applications. Top assignee: Starlight Cardiovascular, Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark S Juravic. Retrieved from https://idiyas.com/inventor/mark-s-juravic-vh42dz5k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mark S Juravic: Innovator in Pediatric Cardiology

Introduction

Mark S Juravic is a notable inventor based in Encinitas, California. He has made significant contributions to the field of pediatric cardiology through his innovative patent. His work focuses on improving the treatment of patients with specific cardiovascular conditions.

Latest Patents

Mark S Juravic holds a patent for "Devices and methods for maintaining a patent ductus arteriosus." This patent describes methods for maintaining a patent ductus arteriosus in pediatric patients. The method involves deploying a self-expanding stent to cover the lumen defined by the ductus arteriosus, which can enhance pulmonary dependent circulation or systemic circulation.

Career Highlights

Mark is associated with Starlight Cardiovascular, Inc., where he applies his expertise in developing medical devices. His innovative approach has the potential to improve outcomes for pediatric patients with cardiovascular issues.

Collaborations

He has collaborated with notable colleagues, including Kathryn A Olson and Vrad W Levering, to advance his work in the field.

Conclusion

Mark S Juravic's contributions to pediatric cardiology through his patent demonstrate his commitment to improving medical treatments for children. His innovative methods have the potential to significantly impact patient care in this specialized area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…